NMDA zzreceptor subtypes - Rationale for future CMS therapies

IDrugs

Volumn 2, Issue 12, 1999, Pages 1313-1326

  Chazot, Paul L ^a   Hawkins, Lynda M ^b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001143344     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (139)

1. •• of outstanding interest
2. • of special interest
3. Watkins JC: The synthesis of some acidic amino acids possessing neuropharmacological activity. J Meet Pharm Chem (1962) 5:1187-1199.
4. Johnson JW, Ascher P: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature (1987) 325:529-531.
5. Kleckner NW, Dingledine R: Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science (1988) 241:835-837.
6. Mayer ML, Westbrook GL, Guthrie PB: Voltage-dependent block by Mg2' of NMDA responses in spinal cord neurons. Nature (1984) 309:261-263.
7. Mayer ML, Westbrook GL: The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol (1987) 28: 97-276.
8. Bliss TVP, Collingridge GL: A synaptic model of memory: long term potentiation in the hippocampus. Nature (1993) 361:31-39.
9. Malenka RC: Synaptic plasticity in the hippocampus: LTP and LTD. Cell (1994) 78:535-538.
10. Komoru H, Rakic P: Modulation of neuronal migration by NMDA receptors. Science (1993) 249:556-560.
11. OIney JW: Excitotoxic amino acids and neuropsychiatrie disorders. Annu Rev Pharmacol Toxicol (1990) 30:47-71.
12. Dingledine R, Mcbain CJ, McNamara JO: Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sei (1990)11:334-338. .
13. Meldrum B, Garthwaite J: Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sei (1990) 11:379-387.
14. Choi D: Excitotoxic cell death. J Neurobiol (1992) 23:12611276.
15. Maragos WF, Greenamyre JT, Penney JB, Young AB: Glutamate dysfunction in Alzheimer's disease: an hypothesis. Trends Neurosci( 1987) 10:65-68.
16. Traynelis SF, Cull-Candy SG: Proton inhibition of /V-methylD-aspartate receptors In cerebellar neurons. Nature (1990) 345:347-350.
17. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S: Molecular cloning and characterization of the rat NMDA receptor. Nature (1991) 354:31-37.
18. Cloning of the first NMDA receptor subunit.
19. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S: Molecular characterization of the family of the W-methyl-D-aspartate receptor subunits. J Biol Chem (1993) 268:2836-2843.
20. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Bumashev N, Sakmann B, Seeburg PH: Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science (1992) 256:1217-1221.
21. Ikeda K, Nagasawa M, Mori H, Araki K, Sakimura K, Watanabe M, Inoue Y, Mishina M: Cloning and expression of the e4 subunit of the NMDA receptor channel. FEES Lett (1992) 313:34-38.
22. Meguro H, Mori H, Araki K, Kushiya E, Kutsuwada T, Yamazaki M, Kumanishi T, Arakawa M, Sakimura K, Mishina M: Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature
23. Yamazaki M, Mori H, Araki K, Mon KJ, Mishina M: Cloning, expression and modulation of a mouse NMDA receptor subunit FEBS Lett (1992) 300:39-45.
24. Kutsuwada T, Kashiwabucchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M: Molecular diversity of the NMDA receptor channel. Nature (1992) 358:36-41.
25. Le Bourdelles B, Wafford KA, Kemp JA, Marshall G. Bain C, Wilcox A, Sikela JM, Whiting PJ: Cloning, functional coexpression, and pharmacological characterization of human cDNAs encoding NMDA receptor NR1 and NR2A subunits. J Neurochem (1994) 62:2091-2098.
26. Karp SJ, Masu M, Eki T, Ozawa K, Nakanishi S: Molecular cloning and chromosomal localization of the key subunit of the human W-methyl-D-aspartate receptor. J Biol Chem
27. Adams SL, Foldes RL, Kamboj RK: Human W-methyl-Daspartate receptor modulatory subunit hNR3: cloning and sequencing of the cDNA and primary structure of the protein. Biochim Biophys Acta (1995) 1260:105-108.
28. Hess SD, Daggett LP, Crona J, Deal C, Lu C-C, Urrutia A, Chavez-Noriega, L, Ellis SB, Johnson EC, Velicelebi G: Cloning and functional characterization of human heteromeric W-methyl-D-aspartate receptors. J Pharmacol Exp 77jer(1996) 278:808-816.
29. Lin YJ, Bovetto S, Carver JM, Giordano T: Cloning of the cDNA for the human NMDA receptor NR2C subunit and its expression in the central nervous system and periphery.
30. Mol Brain Res (1996) 43:57-64.
31. Daggett LP, Johnson EC, Vamey MA, Lin FF, Hess SD, Deal CR, Jachec C, Lu CC, Kemer JA, Landwehrmeyer GB, Standaert DG, Young AB, Harpold MM, Velicelebi G: The human W-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression. J Neurochem (1998) 71:1953-1968.
32. Sucher NJ, Akbarian S, Chi CL, Leclerc CL, Awobuluyi M, Deitcher DL, Wu MK, Yuan JP, Jones EG, Lipton SA: Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J Neurosci (1995) 15:6509-6520.
33. Ciaberra AM, Sullivan JM, Gähn LG, Pecht G, Heinemann S, Sevarino K: Cloning and characterization' of P-1: A developmentally regulated member of a novel class of the lonotropic glutamate receptor family. J Neurosci (1995) 15:6498-6508.
34. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen H-SV, Lipton SA, Nakanishi N: Increased NMDA current and spine density In mice lacking the NMDA receptor subunit NR3A. Nature (1998) 393:377-381.
35. Zukin RS, Bennett MVL: Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurosci (1995) 18:306-313.
36. Suchanek B, Seeburg PH, Sprengel R: Gene structure of the murine N-methyl-D-aspartate receptor subunit NR2C. J Bio! Chem (1995) 270:41 -44.
37. Kuryatov A, Laube B, Betz H, Kuhse J: Mutational analysis of the glyclne-binding site of the NMDA receptor: structural similarity with bacterial' amino acid-binding proteins.
38. Honer M, Benke D, Laube B, Kuhse, J, Heckendom R, Allgeier H, Angst C, Monyer H, Seeburg PH, Betz H, Mohler H: Differentiation of glycine antagonist sites of W-methyl-Daspartate receptor subtypes: Preferential interaction of CGP-61594 with NR1/NR2B receptors. J Biol Chem (1998) 273:11158-11163.
39. Laube B, Hirai H, Sturgess M, Betz H, Kuhse J: Molecular determinants of agonist discrimination by NMDA receptor subunits: Analysis of the glutamate binding site on the NR2B subunit Neuron (1997) 18:493-503.
40. Anson LC, Chen PE, Wyllie DJA, Colquhoun D, Schoepfer R: Identification of amino acid residues of the NR2A subunit that control glutamate potency In recombinant NR1/NR2A NMDA receptors. J Neurose/(1998) 15:581-589.
41. Sucher NJ, Awobuluyi M, Choi YB, Lipton SA: NMDA receptors: from genes to channels. Trends Pharmacol Sei (1996) 17:348-355.
42. Useful, readable review.
43. Monaghan DT, Larsen H: NR1 and NR2 subunit combinations to Ahnethyl-D-aspartate receptor channel blocker pharmacology. J Pharmacol Exp Ther (1997) 280:614-620.
44. Stem P, Behe P, Schoepfer R, Colquhoun D: Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors. Pmc R Soc Lond B Biol Sei (1992) 250:271-277.
45. Cull-Candy SG, Brickley SG, Misra C, Feldmeyer D, Momiyama A, Farrant M: NMDA receptor diversity in the cerebellum: identification of subunits contributing to functional receptors. Neuropharmacology (1998) 37:1369-1380.
46. Brimecombe, JC, Boeckman FA, Aizenman E: Functional consequences of NR2 subunit composition in single recombinant /V-methyl-D-aspartate receptors. Proc Natl AcadSci USA (1997) 94:11019-11024.
47. Williams K: Separating dual effects of zinc at recombinant /Vmethyl-D-aspartate receptors. Neurosci Lett (1996) 215:9-12.
48. Dingledine R, Borges K, Bowie D, Traynelis SF: The glutamate receptor ion channels. Pharm Rev (1999) 51:7-62.
49. Excellent, comprehensive review.
50. Zheng F, Gingrich MB, Traynelis SF, Conn PJ: Tyrosine kinase potentiates NMDA receptor current by reducing tonic Zn" inhibition. Nat Neurosci (1998) 1:185-191.
51. Watanabe M, Inoue Y, Sakimura K, Mishina M: Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport (1992) 3:1138-1140.
52. Meoni P, Bunneman BH, Trist DG, Bowery NG: N-terminal splice variants of the NMDAR1 glutamate receptor subunit: differential expression in human and monkey brain.
53. Neurosci Lett (1998) 249:45-48.
54. • Important observations relating to differences between species.
55. Watanabe M, Inoue Y, Sakimura K, Mishina M: Distinct distributions of five N-methyl-D-aspartate receptor channel subunlt mRNAs In the forebrain. J Comp Neurol (1993) 338:377-390.
56. Monyer H, Bumashev N, Laune DJ, Sakmann B, Seeburg PH: Developmental and regional expression In the rat brain and functional properties of four NMDA receptors. Neuron (1994)12:529-540.
57. Wenzel A, Fritschy JM, Mohler H, Benke D: NMDA receptor heterogeneity during postnatal development of the rat brain: Differential expression of NR2A, NR2B and NR2C subunit proteins. JNeurochem (1995) 68:469-478.
58. Chazot PL, Cik M, Stephenson FA: Immunological detection of the NMDAR1 glutamate receptor subunit expressed in human embryonic kidney 293 cells and in rat brain. J
59. Neurochem (1992) 59:1176-1178.
60. Chazot PL, Stephenson FA: Biochemical evidence for the existence of a pool of unassembled C2 exon-containing NR1 subunits of the mammalian forebrain NMDA receptor.
61. J Neurochem (1997) 68:507-516.
62. Chazot PL, Stephenson FA: Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: Direct demonstration of NMDA receptors comprising NR1, NR2A and NR2B subunits within the same complex. J Neurochem (1997) 69:2138-2144.
63. Sheng M, Cummings J, Rddan LA, Jan YN, Jan LY: Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature (1994) 368:144-147.
64. First indication of complexity of native NMDA receptor subtypes.
65. Brose N Gasic, GP, Vetter DE, Sullivan JM, Heinemann SF: Protein chemical characterization and immunocytochemical localization of the NMDA receptor subunit NMDAR1. JBiol Chem (1993) 268:22663-22671.
66. Blahos J II, Wenthold, RJ: Relationship between N-methyl-Daspartate receptor NR1 splice variants and NR2 subunits.
67. J Biol Chem (1996) 271:15669-15674.
68. Luo J, Wang YH, Yasuda RP, Wolfe BB: The majority of N: methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol (1997) 51:79-86.
69. Charton JP, Herkert M, Becker CM, Schröder H: Cellular and subcellular localization of the NR2B subunit of the NMDA receptor in the adult rat telencephalon. Brain Res (1999) 816:609-617.
70. Thompson CL, Drewery D, Stephenson FA, Chazot PL: Localization of the NR2C/D subunits of the NMDA receptor in murine hippocampus and cerebellum: an immunohistochemistry approach. Br J Pharmacol (Suppl) (1999)127:152.
71. Petralia RS, Wang YX, Wenthold RJ: The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J Neurosci (1994) 14:6102-6120.
72. Johnson RR, Jiang X, Burkhalter A: Regional and laminar differences in synaptic localization of NMDA receptor subunit NR1 splice variants In rat visual cortex and hippocampus. J Comp Neurol (1996) 368:335-355.
73. Standaert DG, Testa CM, Penney JB, Young AB: Alternatively spliced Isoforms of the NMDAR1 glutamate receptor subunit: differential expression in the basal ganglia of the rat. Neurosci Lett (1993) 152:161-164.
74. Wafford KA, Bain CJ, Le Bourdeiles B, Whiting PJ, Kemp JA: Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. Neuroreport (1993) 4:1347-1349.
75. Brimecombe 'JC, Boeckman FA, Aizenman E: Functional consequences of NR2 subunit composition in single recombinant Ahnethyl-D-aspartate receptors. Proc Nati AcadSci USA (1997) 94:11019-11024.
76. Chazot PL, Colemcn SK, Cik M, Stephenson FA: Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J Biol Chem (1994) 269:24403-24409.
77. Didier M, Xu M, Berman SA, Bursztajn S: Differential expression and co-assembly of NMDA Ç1 and e-subunits in mouse cerebellum during postnatal development
78. Chazot PL, Stephenson, FA: Molecular dissection of native mammalian brain NMDA receptors containing the NR2A subunit Naunyn-Schmiedeberg's Arch Pharmacol (1998) 358(Suppl):P11.13.
79. Dunah AW, Luo J, Wang JH, Yasuda RP, Wolfe BB: Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contains the NR2D subunit.
80. Behe P, Stem P, Wyllie DJA, Nassar M, Schoepfer R, Colquhoun D: Determination of NMDA NR1 subunit copy number in recombinant receptors. Proc R Soc Lond Biol Sei (1995) 262:205-213.
81. Premkumar LS, Auerbach A: Stoichiometry of recombinant N-methyl-D-aspartate receptor channels Inferred from single-channel current patterns. J Gen Physiol (1997) 110:485-502.
82. Laube B, Kuhse J, Betz H: Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci (1998)18:2954-2961.
83. Hawkins, LM, Chazot, PL, Stephenson FA: Biochemical evidence for the co-association of three N-methyl-Daspartate (NMDA) R2 subunits in recombinant NMDA receptors. J Biol Chem (1999) 274:27211 -27218.
84. Forrest D, Yuzaki M, Scares HD, Ng L, Luk DC, Sheng M, Stewart CL, Morgan JI, Connor JA, Curran T: Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron (1994) 13:325-338.
85. Kutswada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R et ah Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD In NMDA receptor epsilon 2 subunit mutant mice. Neuron (1996) 16:333-344.
86. Ikeda K, Araki K, Takayama G, Inoue Y, Yagi T, Aizawa S, Mishina M: Reduced spontaneous activity of mice defective In the epsilon 4 subunit of the NMDA receptor channel.
87. Brain Res Mol Brain Res (1995) 33:61 -71.
88. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H, Mishina M: Reduced hippocampal LTP and spatial learning in mice lacking the NMDA receptor epsilon 1 subunit. Nature (1995) 373:151-155.
89. Ebralidze AK, Rossi DJ, Tonegawa S, Slater NT: Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene. J Neurosci (1996) 16:5014-5025.
90. Kadotani H, Hirano T, Masugi M, Nakamura K, Nakao K, Katsuki M, Nakanishi S: Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunits. J Neurosci (1996) 16:7859-7867.
91. Wood PL, Hawkinson JE: N-trtethyl-D-aspartate antagonists for stroke and head trauma. Exp Opin Invest Drugs (1997) 6:389-397.
92. Komhuber J, Weller M: Psychotogenic'rty and N-methyl-Daspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Bbl Psych (1997) 41:135144.
93. Bullock R, Graham Dl, Chen MH, Löwe D, McCulloch J: Focal ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPPene. J Cereb Blood Flow Metab (1990)10:886-674.
94. Scatton B: Excitatory amino acid receptor antagonists: a novel treatment for ischémie cerebrovascular diseases. Life Sc/(1994) 55:2115-2104.
95. Grotta J, Clark W, Coull B, Pettigrew LC, Mackay B, Goldstein LB, Meissner I, Murphy D, LaRue L: Safety and tolerability of the glutamate antagonist CGS-19755 (selfotel) in patients with acute ischémie stroke: results of a phase lia randomized trial. Stroke (1995) 26:602-605.
96. Ellison G: Competitive and non-competitive NMDA antagonists induce similar limbic degeneration.
97. Mirai H, Kirsch J, Laube B, Betz H, Kuhse J: The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: Identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region. Proc NatlAcadSci USA (1996) 93:6031-6036.
98. Gallagher MJ, Huang H, Pritchett DB, Lynch DR: Interactions between ifenprodil and the NR2B subunit of the N-methylD-aspartate receptor. J Biol Chem (1996) 271:9603-9611.
99. Moghan DT, Olverman HJ, Nguyen L, Watkins JC: Two classes of N-methyl-D-aspartate recognition sites: Differential distribution and differential regulation by glycine. Proc NatlAcad Sei USA (1998) 85:9836-9840.
100. Laurie DJ, Seeburg PH: Ligand affinities at recombinant Nmethyl-D-aspartate receptors depend on subunit composition. EurJPharmacol(î994) 268:335-345.
101. Whittemore, ER, llyin VI, Woodward RM: Antagonism of Nmethyl-D-aspartate receptors by slgma site ligands: potency, subtype-selectivity and mechanisms ' of Inhibition. JPharmacol Exp Ther(W97) 282:326-338.
102. Buller AL, Larson HC, Schneider BE, Beaton JA, Morrisett RA, Monaghan DT: The molecular basis of NMDA receptor subtypes: Native receptor diversity is predicted by subunit composition. JNeurosci (1994) 14:5471-5484.
103. • Excellent study which forms a good basis for understanding NMDA receptor subtypes.
104. Woodward RM, Huettner JE, Guastella J, Keana JFW, Weber E: In vitro pharmacology of ACEA-1021 and ACEA-1031: Systemically active qulnoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol Pharmacol (1995) 47:568-581.
105. Grimwood S, Le Bourdelles B, Whiting PJ: Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high affinity glycine antagonist binding site. J Neurochem (1995) 64:525-530.
106. Chopra B, Chazot PL, Mugnaini M, Stephenson FA: A comparison between the binding affinities of two novel glycine site antagonists to cloned NMDA receptor subtypes. BrJ Pharmacol (Suppl) (1999):P159.
107. Kehne JH, Baron BM, Harrison BL, McCloskey TC, Palfreyman MG, Poirot M, Salituro FG, Siegel BW, Slone AL, Vangiersbergen PLM, White HS. MDL-100458 and MDL102288: Two potent and selective glycine receptor antagonists with different functional profiles. Eur J Pharmacol (1995) 284:109-118.
108. Porter RHP, Greenamyre JT: Regional variations in the pharmacology of NMDA receptor channel blockers: Implications for therapeutic potential. J Neurochem (1995) 64:614-623.
109. Carignani C, Ugolini A, Pinnola V, Belardetti F, Trist DG, Corsi M: NMDA receptor subunit characterization of the glycine antagonist GV-196771A and its actions on the spinal cord wind-up. Naunyn-Schmiedeberg's Arch Pharmacol (1998) 358 (Suppl):P11.19.
110. Quartaroli M, Carignani C, Dal Fomo G, Mugnaini M, Ugolini A, Arban R, Bettelini L, Maraia G, Belardetti F, Reggiani A, Trist DG, Ratti E, Di Fabio R, Corsi M: Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV-196771A. J Pharmacol Exp T/7er(1999) 290:158-169.
111. Mott DD, Doherty JJ, Zhang S, Washbum MS, Fendley MJ, Lyuboslavsky P, Traynelis SF, Dingledine R: Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat Neurosci (1998) 1:659-667.
112. Mechanism of action of the newer subtype-selective compounds.
113. Chester M, Kaila K: Modulation of pH by neuronal activity. Trends Neurosci (1992) 15:396-402.
114. Traynelis SF, Hartley M, Heinemann SF: Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science (1995) 268:873-876.
115. Ren K: Wind-up and the NMDA receptor: from animal studies to humans. Pain (1995) 59:157-158.
116. 101.Ying Z, Babb TL, Comair YG, Bingaman W, Bushey M, Touhalisky K: Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex. j
117. Neuropathol Exp A/euro/ (1998) 57:47-62.
118. Rafiki A, Ben-Ari Y, Khrestchatisky M, Represa A: Longlasting enhanced expression in the rat hippocampus of NMDAR1 splice variants in a kainate model of epilepsy.
119. Eor J/Veurosc; (1998) 10:497-507.
120. Vezzani A, Spéciale C, Delia Vedova F, Tamburin M, Benatti: Alternative splicing at the C-terminal but not at the Nterminal domain of the NMDA receptor NR1 is altered in the kindled hippocampus. Eur J Neurosci (1995) 7:2513-2517.
121. Kleckner NW, Gazewski JC, Chen CG, Moscrip TD: Subtype selective antagonism of W-methyl-D-aspartate receptors by felbamate: Insights into the mechanism of action. J
122. PharmacolExp Ther(1999) 289:886-894.
123. Iwasaki Y, Ikeda K, Shiojima T, Kinoshita M: Increased plasma aspartate, glutamate and glycine In Parkinson's disease. Neurosci Lett (1992) 112:251-256.
124. Nash JE, Hill MP, Brotchie JM: Antiparkinsonian actions of blockade of NR2B-conta!ning NMDA receptors in the reserpine-treated rat. Exp Ateuro/(1999) 155:42-48.
125. Schmidt W J, Kretschmer BD: Behavioral pharmacology of glutamate receptors in the basal ganglia. Neurosci Biobehav Rev (1997) 21:381 -392.
126. Bresink I, Benke TA, Colett VJ, Seal AJ, Parsons CG, Henley JM, Collingridge GL: Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 ceils. Br J P/)armaco/(1996) 119:195-204.
127. Verhagen ML, Del Dotto P, Van Den Munckhof P, Fang J, Mouradian MM, Chase TN: Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. A/eura/ogy(1998) 50:1323-1326.
128. Kretschmer BD, Schmidt WJ: Behavioral effects mediated by the modulatory glycine site of the NMDA receptor In the anterodorsal striatum and nucleus accumbens. J Neurosci (1996)16:1561-1569.
129. Lieburtz K: Antiglutamate therapies in Huntington's disease. J Neural Transm Suppl (1999) 55:97-102.
130. Chen N, Luo T, Wellington C, Mettzler M, McCutcheon K, Hayden MR, Raymond LA: Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J Neurochem (1999) 72:1890-1898.
131. • Interesting and potentially important observation.
132. Ferrante RJ, Kowall NW, Béai MF, Richardson Jr EP et ah Selective sparing of a class of striatal neurons in Huntington's disease. Science (1985) 230:561-563.
133. Ishimaru M, Kurumaji A, Tom M: Increases in strychnineinsensitive glycine binding sites in cerebral cortex of chronic schizophrenics: Evidence for glutamate hypothesis. B'iol Psychiatry (1994) 35:84-95.
134. Befgeron R, MeyerTM, Coyle JT, Greene RW: Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc NatlAcadSci USA (1998) 95:15730-15734.
135. • A novel and therapeutically interesting target.
136. Grimwood S, Slater P, Deakin JF, Hutson PH: NR2Bcontaining NMDA receptors are upregulated in temporal cortex in schizophrenia. Neuroreport (\999) 10:461-465.
137. Ehlers MD, Zhang S, Bernhardt JP, Huganir RL: Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit Cell (1996) 84:745-755.
138. • Seminal study in the understanding of the function of NMDA receptors.
139. Chazot PL, Pollard S, Stephenson FA: Immunoprecipitation of receptors. In: General Neurochemical Techniques: Techniques in vitro, Molecular Chapter 12, Boulton A, Baker G, Bateson A (Eds), Humana Press Inc (1998).